Antibiotic Resistance: A Global Threat to Human and Animal Health

The discovery of antibiotics was one of the greatest medical breakthroughs of the 20th century, rendering curable infections that had previously claimed millions of lives. Today, however, we are increasingly confronted with the fact that this fundamental safety net is wavering. The phenomenon of antibiotic resistance—the emergence of antibiotic-resistant "superbugs"—is spreading quietly yet rapidly across the globe. Left unaddressed, it could easily return us to the pre-antibiotic era.

What Is Antibiotic Resistance?

Antibiotic resistance is one of the most severe yet frequently underestimated global health challenges of our time. It occurs when bacteria, fungi, viruses, or parasites become resistant to the drugs designed to treat them.

The phenomenon itself is not new; microbes have adapted to changing environments for millions of years. What is new is the pace of this change. The excessive, inappropriate, or indiscriminate use of antibiotics—in both human and veterinary medicine—has created selective pressure that accelerates the emergence and global spread of resistant bacterial strains.

Today, the World Health Organization (WHO) ranks antibiotic resistance among the top global public health threats facing humanity, affecting human, animal, and environmental health alike.

Antibiotic Resistance in Numbers

The statistics are sobering. According to the 2019 Global Burden of Disease study, nearly 4.95 million deaths annually are associated with bacterial antimicrobial resistance (Murray et al., The Lancet, 2022)—exceeding the annual mortality rates of HIV/AIDS or malaria. Projections indicate that if current trends persist, antibiotic resistance could cause up to 10 million deaths per year by 2050 (O’Neill Review, 2016).

The Development of Antibiotic Resistance

At the molecular level, the development of antibiotic resistance is a complex yet logical process. An antibiotic destroys susceptible bacteria, but if even a single cell survives due to a genetic mutation or resistance gene acquisition, it will multiply. These resistance genes can be inherited by offspring or transferred horizontally between different bacteria. Consequently, multidrug-resistant (MDR) or pandrug-resistant (PDR) strains can emerge in a short span of time.

Particularly concerning is the rise of carbapenem-resistant Enterobacterales strains and MRSA (methicillin-resistant Staphylococcus aureus), which withstand last-resort carbapenem antibiotics used when all other treatments fail.

Levels of Antibiotic Resistance

Scientific literature employs a standardized categorization system to describe the severity of resistance, helping clinicians precisely assess a pathogen's level of defence:

1. MDR (Multidrug-Resistant): The pathogen is resistant to at least one agent in three or more antimicrobial categories. Although treatment options are narrowed, effective therapies are usually still available.

2. XDR (Extensively Drug-Resistant): The bacterium is resistant to almost all available antibiotic classes, leaving only one or two active agents for therapeutic use. Treating these infections presents a major clinical challenge.

3. PDR (Pandrug-Resistant): The most severe category, where the pathogen is resistant to all clinically available antimicrobial agents. In such cases, no standard, proven effective therapy exists, restricting treatment to individualized, combination, or experimental approaches.

These categories are not merely laboratory designations; they correlate directly with shrinking therapeutic options, higher mortality rates, and escalating healthcare expenditures. The emergence of MDR strains acts as an early warning sign, whereas PDR marks the outer boundary of modern antibiotic therapy.

Industrial Livestock Farming as a Primary Driver

More than 27 different classes of antibiotics are used in industrial livestock production. Between 2015 and 2017, 118 countries reported quantitative data on antimicrobial use in animals—a significant increase from 89 countries in 2015. In many regions, antibiotics are still utilized as growth promoters or administered prophylactically to offset infections stemming from poor housing conditions.

Impact on the Global Economy and Humanity

Antimicrobial resistance (AMR) is expected to reach a critical turning point by 2050, by which time it could push an estimated 28 million people into extreme poverty.

Global consequences include:

A 7.5% drop in global food-producing livestock populations due to AMR.
A projected 3.8% decline in global food exports.
Up to a $3 trillion USD increase in global healthcare expenditures.

Impacts on Human Health

Increased morbidity and mortality rates.
Reduced efficacy of critically important human antibiotics.
Rising healthcare costs.
Accelerated evolution of resistance in human pathogens.
Faster, wider dissemination of infectious diseases.

Core pillars of modern medicine—including organ transplants, chemotherapy, neonatal care, and major surgeries—rely on effective antibiotics. AMR does not simply complicate infection management; it threatens the foundation of the entire healthcare system.

What Livestock Producers Can Do

Ensure antimicrobials are administered strictly to treat or control diagnosed infectious diseases under direct veterinary supervision.
Implement vaccination programs and natural antimicrobial alternatives to reduce overall antibiotic demand.
Promote and apply established animal health and hygiene best practices across all stages of food production and processing.
Adopt sustainable farming systems that improve biosecurity, sanitation, and low-stress handling.
Adhere to international standards for responsible antibiotic use set by the WOAH (OIE), FAO, and WHO.

What We Can Do Individually

Use antibiotics only when prescribed specifically for you by a qualified physician.
Always complete the full course of treatment, even if symptoms resolve early.
Never use leftover antibiotics from previous prescriptions.
Never share prescribed antibiotics with others.
Prevent infections by washing hands regularly, avoiding close contact with sick individuals, and staying up to date on recommended vaccinations.

Herbal Antimicrobial Formulations

Demand for effective alternative growth promoters is accelerating worldwide—both in countries where antibiotic growth promoters are banned and in regions preparing for similar restrictions.

Herbal preparations represent a proven alternative that has stood the test of time, delivering consistent results across diverse geographies and livestock species.

Rather than relying on a single target site, herbs work through multi-level, complementary mechanisms. They perform best when administered continuously over set periods, offering distinct operational advantages:

Suitable for general supportive care without requiring complex calibration.
Possess broad safety margins.
Provide heat-stable molecules suitable for feed pelleting processes.
Exert direct and indirect beneficial effects on feed quality, host physiology, and gut microbiota.
Deliver secondary health benefits beyond growth performance and immune support.
Feature complex physicochemical matrices that protect active phytoactive compounds, ensuring long-term stability.

How Herbal Products Reduce Resistant Strains

Inhibit bacterial biofilm formation.
Exert efflux pump (EP) inhibitory activity.
Attenuate bacterial virulence factors.
Provide immunomodulatory support.
Reduce resistance development potential through synergistic phytogenic action.

The value of botanical solutions in veterinary medicine is clear. Driven by their safety and efficacy profile, interest in natural compounds for herd health management has resurged significantly.

Products from AYURVET Ltd. have been used globally for decades to support high-yield livestock operations while reducing antibiotic reliance. Combining standardized herbs and essential oils, AYURVET and its official successor, ZENEX Animal Health Ltd., provide a comprehensive range of natural alternatives to antibiotic growth promoters across all commercial livestock species.

Without prompt, coordinated action, we risk losing the therapeutic power of the antibiotics we depend on today.

Back